The first was a COPD-related mortality and the second was an all-cause mortality rate used to account for deaths from competing causes in the study population.
During the 10 years of follow-up time, 91 patients died from all causes in the study cohort, with median survival not reached.
Nineteen of the 41 excess deaths from cardiovascular causes in the study were attributed to "unexpected or presumed cardiovascular disease," which may plausibly be related to or may have been precipitated by hypoglycemia and misclassified as having a cardiovascular cause.
Nineteen of the 41 excess deaths from cardiovascular causes in the study were attributed to "unexpected or presumed cardiovascular disease," which may plausibly be related to or may have been precipitated by hypoglycaemia and misclassified as having a cardiovascular cause.
It could be shown that second lung cancers caused in the study population an excess of mortality of about six times (P<0.0001), while mortality from other causes was similar.
The high competing risk of death from non-CHD causes in the study population and shorter life expectancies explain the substantially lower value in lifetime risk than that of the theoretical cumulative risk.
Following a major revision of the GBD, a comprehensive re-estimation of disability weights was provided for the full set of around 230 unique sequelae associated with the array of disease and injury causes in the study [ 4].
But there was no link with a lower risk of cancer or dying early from any cause in walkers, the study found.
In the future, analysis on pollution sources and cause factors in the study area should be advanced.
All cause mortality in the study population was 8.1%.
